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CASE REPORT
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Department of Obstetrics and Gynecology, Yale University School ofMedicine,
New Haven, Connecticut
A 66-year-old female presented with a large abdominal mass and accompanying systemic com-
plaints ofabdominalpain, constipation, andfever On exploratory laparotomy, the mass wasfound
to be a moderately differentiated adenocarcinoma ofthe sigmoid colon with metastasis to the left
ovary. A primary colorectal carcinoma that has metastasized to the ovaries can be difficult to dis-
tinguish clinicallyfrom an advancedprimary ovarian tumor Histology and tumor markers are cur-
rently the most useful tools available in making an accurate diagnosis. Ifthe nature ofthe primary
tumor is uncertain andthe initial response to chemotherapy ispoor, thepatient'sprognosis willalso
be poor Though controversy exists regarding the role ofprophylactic bilateral oophorectomy dur-
ing resectionforprimary colorectal cancer, later confusion can be avoided byperforming thispro-
cedure when the colorectal carcinoma isfirst diagnosed. However, the possibility ofa concurrent
primary ovarian tumor must not be overlooked.
INTRODUCTION
The etiology of tumors in the lower
abdomen is sometimes difficult to estab-
lish, both clinically and after standard
investigation. Both the origin of the pri-
mary tumor and the stage of the disease
have considerable influence on the prog-
nosis of patients [1]. For example, a diag-
nosis of ovarian carcinoma infiltrating the
recto-sigmoid region would imply a fair
prognosis following long-term aggressive
chemotherapy; an advanced colorectal
carcinoma with ovarian metastasis, how-
ever, carries a poorer prognosis with little
response to chemotherapy. While a num-
ber ofpapers have been published describ-
ing this diagnostic problem, a clear diag-
nostic approach and therapeutic policy are
lacking. This case report involves a carci-
noma of the sigmoid colon presenting as
an ovarian tumor mass.
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CASE REPORT
A 66-year-old Caucasian woman pre-
sented with abdominal pain, constipation,
and fever of two weeks duration. She had
a complicated medical history that includ-
ed a subtotal hysterectomy for benign dis-
ease with conservation ofthe ovaries and a
right mastectomy with axillary dissection
and radiotherapy for breast cancer, which
had been in remission for 10 years. On
examination, a hypogastric mass extend-
ing into the left iliac fossa was palpated.
The mass was fixed in the pelvis and mea-
sured 11 x 16 cm. Laboratory values were
notable for an increased C-reactive protein
level (16 mg/100ml, N 0-1 mg/100 ml)
and CA-125 level (295 IU/1, N < 35 IU/1).
The CEAb level was found to be within
normal limits. A pelvic MRI scan showed
the mass to be irregular and partially solid.
It did not appear to originate from either
the cervix or the bladder, or to be invading
the rectum or sigmoid colon (Figure 1).
There was no evidence of ascites, but
enlarged lymph nodes were detected in the
left common iliac chain. A barium enema
revealed an irregular stenosis in a 6 cm
region of the sigmoid colon, representing
either a primary tumor or direct invasion
from outside the lumen.
At laparotomy, a mass was found in
the left adnexa measuring 11 x 11 x 7 cm
and weighing 1050 grams. This mass was
white and loculated in appearance, with
both solid and necrotic areas. Examination
of the colon confirmed an indurated zone
at the level of the sigmoid stenosis. The
operation was completed with simultane-
ous bilateral oophorectomy, lymphadenec-
tomy, omentectomy, and partial colectomy
(20 cm in length). Macroscopically, the
sigmoid tumor was an ulcerated, stenotic
mass of 3 cm diameter invading the entire
thickness of the bowel wall. The resection
margins were free of tumor. The final
histopathology report suggested a moder-
ately differentiated adenocarcinoma ofthe
sigmoid colon with metastasis to the left
ovary. The study of a number of immuno-
histochemical markers on a section of the
excised left ovary confirmed the tumor to
be ofdigestive origin.
After six courses of adjuvant
chemotherapy with 5-fluorouracil and
folinic acid rescue, the CA-125 level was
Figure 1. Sagittal pelvic MRI scans revealing a large, irregularly shaped pelvic mass
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found to be in normal range and no longer
elevated. A follow-up MRI scan six
months later, however, revealed two large
pelvic masses compressing the right
ureter. To cover the possibility of an ovar-
ian primary, the patient was then treated
with four doses of carboplatin and
cyclophosphamide. A repeat MRI scan
showed the masses to be larger and more
heterogeneous than before, the largest
measuring 10.7 x 12.4 x 11.4 cm, displac-
ing and compressing the rectum and the
bladder, and causing bilateral
hydronephroses. The origin ofthese mass-
es was still unclear. A nephrostomy tube
was sited to drain the build-up of fluid in
the kidneys, and the patient was started on
a course of paclitaxel. After four courses,
the masses continued to enlarge. At the
patient's request, the treatment was contin-
ued, this time with weekly courses ofhigh
dose 5-fluorouracil. Thepatientdied, how-
ever, after the sixth course oftreatment.
DISCUSSION
Ovarian metastases represent up to 20
percent of malignant tumors of the ovary,
are usually bilateral (50 to 70 percent of
cases), and are often occult (6 to 25 per-
cent) [1, 2, 3]. The primary tumor can
originate in bowel (usually gastric or
colonic), breast, thyroid, adrenal, or blad-
der tissue. Malignant melanoma can also
metastasize to the ovary. Colorectal carci-
noma metastasizes to the ovaries in up to
10 percent of cases [2, 4]. In these situa-
tions, the incidence of ovarian involve-
ment does not appear to be dependent on
the size, stage, or degree ofdifferentiation
of the primary tumor [5]. However, the
risk significantly increases during the
reproductive years [6], and the preferred
route of spread appears to be hematoge-
nous, although transcoelomic spread can
also occur in some cases.
Ovarian metastases tend not to pre-
sent as large masses, as in this case report.
When they do, however, they are easily
confused with a primary ovarian tumor.
The clinical symptoms ofmetastatic ovar-
ian disease are similar to those ofprimary
epithelial carcinomas ofthe ovary. Ifthere
are no specific symptoms from the prima-
ry site to alert the clinician, the presenting
symptoms may be no more than a fever of
unknown origin, chronic abdominal bloat-
ing, constipation, and vague lower abdom-
inal pain, often described as a "dragging"
sensation or a feeling of heaviness. Care-
ful abdominal palpation and a bimanual
pelvic examination may reveal a mass and
give cause for further investigation.
The tumor marker CA-125 is raised in
80 to 90 percent of primary ovarian ade-
nocarcinomas [7, 8], but is non-specific
and can be elevated in a variety ofbenign
diseases. As this case illustrates, it can also
be raised in metastatic ovarian disease and
is not reliable as a marker to follow treat-
ment progress.
In this case, an MRI scan was per-
formed without recourse to CT scan or
ultrasound due to the acute nature of the
patient's symptoms and the need for a
rapid diagnosis. MRI scans [9] may be
more accurate than CT scans in distin-
guishing primary ovarian tumors from
metastases, but data are limited. The use of
transvaginal ultrasound scanning with
Doppler studies have also proven to be
useful in the evaluation of ovarian masses
[8, 10, 11]. Krukenberg tumors have been
shown to have ultrasonographic features
that distinguish them from ovarian pri-
maries [11], but there are no other studies
which focus on other types of ovarian
metastases. If it is suspected that the pri-
mary tumor is colonic, a barium enema
should be performed promptly, with other
imaging techniques kept in reserve. Often
the final diagnosis can only be made with
authority by the histopathology depart-
ment. Cytokeratin immunohistochemical
staining is also a useful adjunct in the dif-
ferential diagnosis.104 Shin et al.: Prophylactic oophorectomy in colorectal cancer
There appears to be a definite trend
toward routine bilateral oophorectomy as
part of the treatment for colorectal tumors
[6, 12, 13, 14] as the high frequency of
these insidious metastases is recognized,
but this is still a point of contention. It is
known that macroscopic ovarian metas-
tases found at the time of operation for
colorectal carcinoma carry a poor progno-
sis [15]; however, the evidence for pro-
phylactic oophorectomy in the absence of
macroscopic disease is conflicting [16,
17], especially in the pre-menopausal
patient. The median survival for a patient
with an ovarian metastasis is 18 months.
Some series report afive-year survival rate
of 33 percent with prophylactic oophorec-
tomy [18], which might justify the more
aggressive approach of removing the
ovaries in a curative attempt. Results from
larger prospective studies are expected to
address this controversial issue [19]. Some
authors claim that the only real benefit to
prophylactic oophorectomy lies in the pre-
vention of a primary ovarian tumor in the
post-menopausal group [5, 20], but other
studies contend that menopausal status has
no effect on patient outcomes [15, 17].
A retrospective study on women with
a history ofcolorectal carcinoma undergo-
ing oophorectomy for a new tumor
revealed an ovarian metastasis in 57 per-
cent of cases and primary ovarian neo-
plasms in only 13 percent. The prognosis
for an ovarian carcinoma which has not
responded to first- and second-line
chemotherapy is as poor as that for a pri-
mary colorectal tumor with ovarian metas-
tasis [21]. Thus, there seems to be little
benefit to the patient in pursuing further
chemotherapeutic options in cases where
the nature of the primary is still in doubt.
CONCLUSION
The possibility of an ovarian metasta-
sis must be considered early to avoid con-
fusion in more advanced disease, to guide
the choice oftreatment, and to improve the
accuracy of prognostic prediction. We
consider no malignant ovarian tumor to be
fully investigated until the gastrointestinal
system has been fully assessed. Converse-
ly, we recommend careful examination
with or without biopsy of both ovaries
whenever a colectomy is carried out for
malignant disease. Such patients should
also receive gynecologic follow-up
including transvaginal ultrasound scans.
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